| Affiliation: | 1. Department of Oncology and Hemato-Oncology, Division of Early Drug Development, European Institute of Oncology, IRCCS and University of Milano, Milan, Italy;2. Gynaecology Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK;3. Department of Medical Oncology, Biomedical Research Institute, INCLIVA, University of Valencia, Valencia, Spain;4. Hematology and Medical Oncology, CIBERONC Instituto de Salud Carlos III, Madrid, Spain;5. Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;6. Medical Oncology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, Spain;7. Thoracic Oncology, Université de Lyon, Université Claude Bernard Lyon, Lyon, France;8. Thoracic Surgery, Département Oncologie Médicale, Institut Curie, Paris, France;9. Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands;10. Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany;11. Department of Institut Roi Albert II, University Cancer Center Leipzig, Leipzig University Medical Center, Leipzig, Germany;12. Institut Roi Albert II, Service d''Oncologie Médicale, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (POLE MIRO), Université Catholique de Louvain, Brussels, Belgium;13. Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland;14. Department of Medical Oncology, Vall d''Hebron University Hospital and Vall d''Hebron Institute of Oncology (VHIO), Barcelona, Spain;15. Department of Medical Oncology, Centre René Gauducheau, Nantes, France;16. Department of Medical Oncology, Medical School, University of Ioannina, Ioannina, Epirus, Greece |
